Mac Davis of Minicircle on The Challenges and Opportunities in the Gene Therapy Space

Mac Davis never planned on revolutionizing human health through gene therapy. A serial biotechnology entrepreneur, he founded Minicircle after developing a groundbreaking transient genetic enhancement platform. In this episode, Davis shares his journey from scientific researcher to innovative startup founder, discussing the potential of hormones like statin to optimize muscle health, reduce inflammation, and potentially slow aging. He explores the challenges of building a gene therapy company, early investor support from Sam Altman and Peter Thiel, and his vision of making personalized health interventions as accessible as a routine medical treatment.